Skip to main page content

Comment

. 2016 Aug;17(8):1029-1030.

doi: 10.1016/S1470-2045(16)30152-8. Epub 2016 Jul 7.

Combined modality adjuvant therapy for high-risk endometrial cancer

Adriaan Vanderstichele¹, Patrick Neven², Ignace Vergote¹

Affiliations

Affiliations

¹ Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium; Division of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
² Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium; Division of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Electronic address: patrick.neven@uz.kuleuven.ac.be.

PMID: 27397044
DOI: 10.1016/S1470-2045(16)30152-8

Free article

Comment

Combined modality adjuvant therapy for high-risk endometrial cancer

Adriaan Vanderstichele et al. Lancet Oncol. 2016 Aug.

Free article

. 2016 Aug;17(8):1029-1030.

doi: 10.1016/S1470-2045(16)30152-8. Epub 2016 Jul 7.

Authors

Adriaan Vanderstichele¹, Patrick Neven², Ignace Vergote¹

Affiliations

¹ Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium; Division of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
² Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium; Division of Gynaecological Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Electronic address: patrick.neven@uz.kuleuven.ac.be.

PMID: 27397044
DOI: 10.1016/S1470-2045(16)30152-8

No abstract available

PubMed Disclaimer

Comment on

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Kitchener HC, Nijman HW, Kruitwagen RF, Nout RA, Verhoeven-Adema KW, Smit VT, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Lancet Oncol. 2016 Aug;17(8):1114-1126. doi: 10.1016/S1470-2045(16)30120-6. Epub 2016 Jul 7. Lancet Oncol. 2016. PMID: 27397040 Clinical Trial.

Similar articles

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA. Alvarez Secord A, et al. Gynecol Oncol. 2007 Nov;107(2):285-91. doi: 10.1016/j.ygyno.2007.06.014. Epub 2007 Aug 6. Gynecol Oncol. 2007. PMID: 17688923
Management of endometrial cancer.
Fowler W, Mutch D. Fowler W, et al. Womens Health (Lond). 2008 Sep;4(5):479-89. doi: 10.2217/17455057.4.5.479. Womens Health (Lond). 2008. PMID: 19072487 Review.
ACOG Practice Bulletin number 65: management of endometrial cancer.
Hernandez E; American College of Obstericians and Gynecologists. Hernandez E, et al. Obstet Gynecol. 2006 Apr;107(4):952; author reply 952-3. doi: 10.1097/01.AOG.0000209463.53764.e7. Obstet Gynecol. 2006. PMID: 16582139 No abstract available.
What role does adjuvant therapy play in the management of endometrial cancer?
Huang GS, Tymon-Rosario J, Santin AD. Huang GS, et al. Expert Opin Pharmacother. 2023 Jan;24(1):7-10. doi: 10.1080/14656566.2022.2157207. Epub 2023 Jan 3. Expert Opin Pharmacother. 2023. PMID: 36594708 No abstract available.
Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y, Hanna RK, Elshaikh MA. Xu Y, et al. Arch Gynecol Obstet. 2016 Mar;293(3):485-92. doi: 10.1007/s00404-015-3973-x. Epub 2015 Dec 1. Arch Gynecol Obstet. 2016. PMID: 26626183 Review.

See all similar articles

Cited by

Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer.
Feng W, Jia N, Jiao H, Chen J, Chen Y, Zhang Y, Zhu M, Zhu C, Shen L, Long W. Feng W, et al. J Transl Med. 2021 Feb 3;19(1):51. doi: 10.1186/s12967-021-02722-8. J Transl Med. 2021. PMID: 33536036 Free PMC article.
Endometrial cancer: mapping the global landscape of research.
Brüggmann D, Ouassou K, Klingelhöfer D, Bohlmann MK, Jaque J, Groneberg DA. Brüggmann D, et al. J Transl Med. 2020 Oct 12;18(1):386. doi: 10.1186/s12967-020-02554-y. J Transl Med. 2020. PMID: 33046107 Free PMC article.
Effects of RNAi-induced Skp2 inhibition on cell cycle, apoptosis and proliferation of endometrial carcinoma cells.
Lin H, Ruan GY, Sun XQ, Chen XY, Zheng X, Sun PM. Lin H, et al. Exp Ther Med. 2019 May;17(5):3441-3450. doi: 10.3892/etm.2019.7392. Epub 2019 Mar 13. Exp Ther Med. 2019. PMID: 30988723 Free PMC article.
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
Ma AY, Xie SW, Zhou JY, Zhu Y. Ma AY, et al. Int J Mol Sci. 2017 Jun 22;18(7):1337. doi: 10.3390/ijms18071337. Int J Mol Sci. 2017. PMID: 28640224 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance